tsukiko.kurokawa@metagentx.com (Yamagata, Japan, May 30, 2024) Metagen Therapeutics, Inc. (Headquarters: Tsuruoka City, Yamagata Prefecture; President & CEO: Taku Nakahara), a company focusing on drug discovery and development of intestinal microbiome-based therapeutics for various diseases, will have its Chief Medical Officer Dai Ishikawa as speaker at 10th International Human Microbiome Consortium Congress 2024, to be held from June 22, 2024 to June 25, 2024 in Rome, Italy.
The IHMC is an international conference that brings together researchers in the field of microbiome from around the world.
For more information, please visit the following website:
■『10th International Human Microbiome Consortium Congress 2024』